How I treat extramedullary acute myeloid leukemia

Blood

Volumn 118, Issue 14, 2011, Pages 3785-3793

  Bakst, Richard L ^a   Tallman, Martin S ^a   Douer, Dan ^a   Yahalom, Joachim ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; AZACITIDINE; CD135 ANTIGEN; CLOFARABINE; CYTARABINE; NUCLEOPHOSMIN; RETINOIC ACID; TRANSCRIPTION FACTOR RUNX1;

ACUTE GRANULOCYTIC LEUKEMIA; ASPIRATION BIOPSY; BONE MARROW BIOPSY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHROMOSOME ABERRATION; CHRONIC MYELOID LEUKEMIA; CLINICAL PRACTICE; COMPUTER ASSISTED TOMOGRAPHY; CYTOGENETICS; DIFFERENTIAL DIAGNOSIS; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE MUTATION; GRANULOCYTIC SARCOMA; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LEUKEMIA CELL; LEUKEMIA RELAPSE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SKIN LEUKEMIA; SKIN TOXICITY; TREATMENT RESPONSE;

EID: 80053635652     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-04-347229     Document Type: Review

References (113)

1. Burns A. Observations of Surgical Anatomy in Head and Neck. Edinburgh, United Kingdom: Thomas Royce; 1811.
2. King A. A case of chloroma. Monthly J Med. 1853;17:97.
3. Reardon G, Moloney WC. Chloroma and related myeloblastic neoplasms. Arch Intern Med. 1961;108:864-871.
4. Dock G, Warthin A. A new case of chloroma with leukemia. Trans Assoc Am Phys. 1904;19:64-115.
5. Rappaport H. Tumors of the hematopoietic system. In: Atlas of Tumor Pathology, Section III, Fascicle 8. Washington, DC: Armed Forces Institute of Pathology; 1967.
6. Longacre TA, Smoller BR. Leukemia cutis: analysis of 50 biopsy-proven cases with an emphasis on occurrence in myelodysplastic syndromes. Am J Clin Pathol. 1993;100(3):276-284. (Pubitemid 23268653)
7. Cho-Vega JH, Medeiros LJ, Prieto VG, Vega F. Leukemia cutis. Am J Clin Pathol. 2008;129(1):130-142. (Pubitemid 352038602)
8. Liu PI, Ishimaru T, McGregor DH, Okada H, Steer A. Autopsy study of granulocytic sarcoma (chloroma) in patients with myelogenous leukemia, Hiroshima-Nagasaki 1949-1969. Cancer. 1973;31(4):948-955.
9. Neiman RS, Barcos M, Berard C, et al. Granulocytic sarcoma: a clinicopathologic study of 61 biopsied cases. Cancer. 1981;48(6):1426-1437. (Pubitemid 11042596)
10. Wiernik PH, Serpick AA. Granulocytic sarcoma (chloroma). Blood. 1970;35(3):361-369.
11. Krause JR. Granulocytic sarcoma preceding acute leukemia: a report of six cases. Cancer. 1979;44(3):1017-1021. (Pubitemid 10242237)
12. Eshghabadi M, Shojania AM, Carr I. Isolated granulocytic sarcoma: report of a case and review of the literature. J Clin Oncol. 1986;4(6):912-917. (Pubitemid 16080945)
13. Meis JM, Butler JJ, Osborne BM, Manning JT. Granulocytic sarcoma in nonleukemic patients. Cancer. 1986;58(12):2697-2709. (Pubitemid 17232931)
14. Byrd JC, Edenfield WJ, Shields DJ, Dawson NA. Extramedullary myeloid cell tumors in acute non-lymphocytic leukemia: a clinical review. J Clin Oncol. 1995;13(7):1800-1816.
15. Tallman MS, Hakimian D, Shaw JM, et al. Granulocytic sarcoma is associated with the 8;21 translocation in acute myeloid leukemia. J Clin Oncol. 1993;11(4):690-697. (Pubitemid 23105677)
16. Szomor A, Passweg JR, Tichelli A, et al. Myeloid leukemia and myelodysplastic syndrome relapsing as granulocytic sarcoma (chloroma) after allogeneic bone marrow transplantation. Ann Hematol. 1997;75(5):239-241. (Pubitemid 27526241)
17. Bekassy AN, Hermans J, Gorin NC, Gratwohl A. Granulocytic sarcoma after allogeneic bone marrow transplantation: a retrospective European multicenter survey: Acute and Chronic Leukemia Working Parties of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant. 1996;17(5):801-808. (Pubitemid 26156317)
18. Agis H, Weltermann A, Fonatsch C, et al. A comparative study on demographic, hematological, and cytogenetic findings and prognosis in acute myeloid leukemia with and without leukemia cutis. Ann Hematol. 2002;81(2):90-95. (Pubitemid 36067582)
19. Boggs DR, Wintrobe MM, Cartwright GE. The acute leukemias: analysis of 322 cases and review of the literature. Medicine (Baltimore). 1962;41:163-225.
20. Kaddu S, Zenahlik P, Beham-Schmid C, Kerl H, Cerroni L. Specific cutaneous infiltrates in patients with myelogenous leukemia: a clinicopathologic study of 26 patients with assessment of diagnostic criteria. J Am Acad Dermatol. 1999;40(6):966-978. (Pubitemid 29268929)
21. Tobelem G, Jacquillat C, Chastang C, et al. Acute monoblastic leukemia: a clinical and biologic study of 74 cases. Blood. 1980;55(1):71-76. (Pubitemid 10211899)
22. Resnik KS, Brod BB. Leukemia-cutis in congenital leukemia: analysis and review of the world literature with report of an additional case. Arch Dermatol. 1993;129(10):1301-1306. (Pubitemid 23296742)
23. Paydas S, Zorludemir S, Ergin M. Granulocytic sarcoma: 32 cases and review of the literature. Leuk Lymphoma. 2006;47(12):2527-2541. (Pubitemid 44932643)
24. Verra WC, Snijders TJ, Seute T, et al. Myeloid sarcoma presenting as a recurrent, multifocal nerve root entrapment syndrome. J Neurooncol. 2009;91(1):59-62.
25. Widhalm G, Dietrich W, Mullauer L, et al. Myeloid sarcoma with multiple lesions of the central nervous system in a patient without leukemia: case report. J Neurosurg. 2006;105(6):916-919. (Pubitemid 44917398)
26. Struhal W, Oberndorfer S, Lahrmann H, et al. Myeloid sarcoma in the central nervous system: case report and review of the literature. Acta Clin Croat. 2008;47(1):19-24.
27. Su WP. Clinical, histopathologic, and immunohistochemical correlations in leukemia cutis. Semin Dermatol. 1994;13(3):223-230. (Pubitemid 24276941)
28. Tomasini C, Quaglino P, Novelli M, Fierro MT. "Aleukemic" granulomatous leukemia cutis. Am J Dermatopathol. 1998;20(4):417-421.
29. Watson KM, Mufti G, Salisbury JR, Du Vivier AW, Creamer D. Spectrum of clinical presentation, treatment and prognosis in a series of eight patients with leukaemia cutis. Clin Exp Dermatol. 2006;31(2):218-221.
30. Ratnam KV, Khor CJ, Su WP. Leukemia cutis. Dermatol Clin. 1994;12(2):419-431. (Pubitemid 24149726)
31. Paydas S, Zorludemir S. Leukaemia cutis and leukaemic vasculitis. Br J Dermatol. 2000;143(4):773-779.
32. Lee JI, Park HJ, Oh ST, Lee JY, Cho BK. A case of leukemia cutis at the site of a prior catheter insertion. Ann Dermatol. 2009;21(2):193-196.
33. Kim HS, Choi MJ, Kim HO, Park YM. Leukemia cutis limited to the needle puncture sites. J Dermatol. 2010;37(4):393-395.
34. Traweek ST, Arber DA, Rappaport H, Brynes RK. Extramedullary myeloid cell tumors: an immunohistochemical and morphologic study of 28 cases. Am J Surg Pathol. 1993;17(10):1011-1019. (Pubitemid 23289343)
35. Pileri SA, Ascani S, Cox MC, et al. Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients. Leukemia. 2007;21(2):340-350. (Pubitemid 46158129)
36. Campidelli C, Agostinelli C, Stitson R, Pileri SA. Myeloid sarcoma: extramedullary manifestation of myeloid disorders. Am J Clin Pathol. 2009;132(3):426-437.
37. Breccia M, Mandelli F, Petti MC, et al. Clinicopathological characteristics of myeloid sarcoma at diagnosis and during follow-up: report of 12 cases from a single institution. Leuk Res. 2004;28(11):1165-1169. (Pubitemid 39243240)
38. Ngu IW, Sinclair EC, Greenaway S, Greenberg ML. Unusual presentation of granulocytic sarcoma in the breast: a case report and review of the literature. Diagn Cytopathol. 2001;24(1):53-57. (Pubitemid 32039046)
39. Cronin DM, George TI, Sundram UN. An updated approach to the diagnosis of myeloid leukemia cutis. Am J Clin Pathol. 2009;132(1):101-110.
40. Bonig H, Gobel U, Nurnberger W. Bilateral exopthalmus due to retro-orbital chloromas in a boy with t(8;21)-positive acute myeloblastic acute leukemia. Pediatr Hematol Oncol. 2002;19(8):597-600. (Pubitemid 35398083)
41. Zhang XH, Zhang R, Li Y. Granulocytic sarcoma of abdomen in acute myeloid leukemia patient with inv(16) and t(6;17) abnormal chromosome: case report and review of literature. Leuk Res. 2010;34(7):958-961.
42. Sugimoto Y, Nishii K, Sakakura M, et al. Acute myeloid leukemia with t(8;21)(q22;q22) manifesting as granulocytic sarcomas in the rhinopharynx and external acoustic meatus at relapse after high-dose cytarabine: case report and review of the literature. Hematol J. 2004;5(1):84-89. (Pubitemid 38262796)
43. Schwyzer R, Sherman GG, Cohn RJ, Poole JE, Willem P. Granulocytic sarcoma in children with acute myeloblastic leukemia and t(8;21). Med Pediatr Oncol. 1998;31(3):144-149. (Pubitemid 28387910)
44. Maseki N, Miyoshi H, Shimizu K, et al. The 8;21 chromosome translocation in acute myeloid leukemia is always detectable by molecular analysis using AML1. Blood. 1993;81(6):1573-1579. (Pubitemid 23083837)
45. Xavier SG, Fagundes EM, Hassan R, et al. Granulocytic sarcoma of the small intestine with CBFbeta/MYH11 fusion gene: report of an aleukaemic case and review of the literature. Leuk Res. 2003;27(11):1063-1066. (Pubitemid 36809077)
46. Bloomfield CD, Lawrence D, Byrd JC, et al. Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype. Cancer Res. 1998;58(18):4173-4179. (Pubitemid 28440576)
47. Park KU, Lee DS, Lee HS, Kim CJ, Cho HI. Granulocytic sarcoma in MLL-positive infant acute myelogenous leukemia: fluorescence in situ hybridization study of childhood acute myelogenous leukemia for detecting MLL rearrangement. Am J Pathol. 2001;159(6):2011-2016.
48. Leblanc T, Le Coniat M, Flexor M, et al. An interstitial 11q23 deletion proven to be a rearrangement interrupting the MLL gene in an infant with acute myeloblastic leukemia. Leukemia. 1996;10(11):1844-1846. (Pubitemid 26380036)
49. Hagemeijer A, Hahlen K, Sizoo W, Abels J. Translocation (9;11)(p21;q23) in three cases of acute monoblastic leukemia. Cancer Genet Cytogenet. 1982;5(2):95-105. (Pubitemid 13185839)
50. Dachary D, Bernard P, Lacombe F, et al. Acute myeloid leukemia with marrow hypereosinophilia and chromosome 16 abnormality. Cancer Genet Cytogenet. 1986;20(3):241-246. (Pubitemid 16153278)
51. Miura I, Nishinari T, Hashimoto K, et al. Translocation (8;17)(p21;q21), a possible variant of t(15;17), in acute promyelocytic leukemia. Cancer Genet Cytogenet. 1994;72(1):75-77. (Pubitemid 24161934)
52. Bernstein R, Pinto MR, Spector I, Macdougall LG. A unique 8;16 translocation in two infants with poorly differentiated monoblastic leukemia. Cancer Genet Cytogenet. 1987;24(2):213-220. (Pubitemid 17231506)
53. Douet-Guilbert N, Morel F, Le Bris MJ, et al. Rearrangement of MLL in a patient with congenital acute monoblastic leukemia and granulocytic sarcoma associated with a t(1;11)(p36;q23) translocation. Leuk Lymphoma. 2005;46(1):143-146.
54. Baer MR, Barcos M, Farrell H, Raza A, Preisler HD. Acute myelogenous leukemia with leukemia cutis: eighteen cases seen between 1969 and 1986. Cancer. 1989;63(11):2192-2200. (Pubitemid 19136854)
55. Sen F, Zhang XX, Prieto VG, Shea CR, Qumsiyeh MB. Increased incidence of trisomy 8 in acute myeloid leukemia with skin infiltration (leukemia cutis). Diagn Mol Pathol. 2000;9(4):190-194.
56. Ferrara F, Cancemi D, Friso P, et al. Tetrasomy 8 and t(1;11)(p32;q24) in acute myelo-monocytic leukemia with extensive leukemic cutaneous involvement. Leuk Lymphoma. 1996;20(5):513-515. (Pubitemid 26096063)
57. Gould J, Iqbal A, Heath M, et al. Pentasomy 8 in acute monoblastic leukemia. Cancer Genet Cytogenet. 2000;117(2):146-148. (Pubitemid 30125816)
58. Evans GD, Grimwade DJ. Extramedullary disease in acute promyelocytic leukemia. Leuk Lymphoma. 1999;33(3):219-229. (Pubitemid 29196859)
59. Vega-Ruiz A, Faderl S, Estrov Z, et al. Incidence of extramedullary disease in patients with acute promyelocytic leukemia: a single-institution experience. Int J Hematol. 2009;89(4):489-496.
60. Montesinos P, Diaz-Mediavilla J, Deben G, et al. Central nervous system involvement at first relapse in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline monochemotherapy without intrathecal prophylaxis. Haematologica. 2009;94(9):1242-1249.
61. Grignani F, Ferrucci PF, Testa U, et al. The acute promyelocytic leukemia-specific PML-RAR alpha fusion protein inhibits differentiation and promotes survival of myeloid precursor cells. Cell. 1993;74(3):423-431. (Pubitemid 23244608)
62. Specchia G, Lo Coco F, Vignetti M, et al. Extramedullary involvement at relapse in acute promyelocytic leukemia patients treated or not with all-trans retinoic acid: a report by the Gruppo Italiano Malattie Ematologiche dell'Adulto. J Clin Oncol. 2001;19(20):4023-4028. (Pubitemid 32976688)
63. De Botton S, Sanz MA, Chevret S, et al. Extramedullary relapse in acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy. Leukemia. 2006;20(1):35-41.
64. Schlenk RF, Dohner K, Krauter J, et al. Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia. N Engl J Med. 2008;358(18):1909-1918. (Pubitemid 351620111)
65. Falini B, Lenze D, Hasserjian R, et al. Cytoplasmic mutated nucleophosmin (NPM) defines the molecular status of a significant fraction of myeloid sarcomas. Leukemia. 2007;21(7):1566-1570. (Pubitemid 46965302)
66. Ansari-Lari MA, Yang CF, Tinawi-Aljundi R, et al. FLT3 mutations in myeloid sarcoma. Br J Haematol. 2004;126(6):785-791. (Pubitemid 39273818)
67. Pui MH, Fletcher BD, Langston JW. Granulocytic sarcoma in childhood leukemia: imaging features. Radiology. 1994;190(3):698-702. (Pubitemid 24071032)
68. Bakst R, Wolden SL, Yahalom J. Radiation therapy for chloroma (granulocytic sarcoma). Int J Radiat Oncol Biol Phys. In press.
69. Kook H, Hwang TJ, Kang HK, Kim SH, Kim JH. Spinal intramedullary granulocytic sarcoma: magnetic resonance imaging. Magn Reson Imaging. 1993;11(1):135-137.
70. Fritz J, Vogel W, Bares R, Horger M. Radiologic spectrum of extramedullary relapse of myelogenous leukemia in adults. AJR Am J Roentgenol. 2007;189(1):209-218. (Pubitemid 46983213)
71. Lan TY, Lin DT, Tien HF, et al. Prognostic factors of treatment outcomes in patients with granulocytic sarcoma. Acta Haematol. 2009;122(4):238-246.
72. Tsimberidou AM, Kantarjian HM, Estey E, et al. Outcome in patients with nonleukemic granulocytic sarcoma treated with chemotherapy with or without radiotherapy. Leukemia. 2003;17(6):1100-1103. (Pubitemid 36733479)
73. Ruiz-Arguelles GJ, Morales-Toquero A, Manzano C, et al. t(8;21) (q22;q22) acute myelogenous leukemia in Mexico: a single institution experience. Hematology. 2006;11(4):235-238. (Pubitemid 44963699)
74. Byrd JC, Weiss RB, Arthur DC, et al. Extramedullary leukemia adversely affects hematologic complete remission rate and overall survival in patients with t(8;21)(q22;q22): results from Cancer and Leukemia Group B 8461. J Clin Oncol. 1997;15(2):466-475. (Pubitemid 27075134)
75. Tsimberidou AM, Kantarjian HM, Wen S, et al. Myeloid sarcoma is associated with superior event-free survival and overall survival compared with acute myeloid leukemia. Cancer. 2008;113(6):1370-1378.
76. Yamauchi K, Yasuda M. Comparison in treatments of nonleukemic granulocytic sarcoma: report of two cases and a review of 72 cases in the literature. Cancer. 2002;94(6):1739-1746. (Pubitemid 34241112)
77. Hayashi T, Kimura M, Satoh S, et al. Early detection of AML1/MTG8 fusion mRNA by RT-PCR in the bone marrow cells from a patient with isolated granulocytic sarcoma. Leukemia. 1998;12(9):1501-1503. (Pubitemid 28442404)
78. Imrie KR, Kovacs MJ, Selby D, et al. Isolated chloroma: the effect of early antileukemic therapy. Ann Intern Med. 1995;123(5):351-353.
79. Reinhardt D, Creutzig U. Isolated myelosarcoma in children: update and review. Leuk Lymphoma. 2002;43(3):565-574. (Pubitemid 34232924)
80. Dohner H, Estey EH, Amadori S, et al. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. Blood. 2010;115(3):453-474.
81. Chevallier P, Mohty M, Lioure B, et al. Allogeneic hematopoietic stem-cell transplantation for myeloid sarcoma: a retrospective study from the SFGM-TC. J Clin Oncol. 2008;26(30):4940-4943.
82. Lowenberg B, Pabst T, Vellenga E, et al. Cytarabine dose for acute myeloid leukemia. N Engl J Med. 2011;364(11):1027-1036.
83. Burnett A, Wetzler M, Lowenberg B. Therapeutic advances in acute myeloid leukemia. J Clin Oncol. 2011;29(5):487-494.
84. Fernandez HF, Sun Z, Yao X, et al. Anthracycline dose intensification in acute myeloid leukemia. N Engl J Med. 2009;361(13):1249-1259.
85. Byrd JC, Weiss RB. Recurrent granulocytic sarcoma: an unusual variation of acute myelogenous leukemia associated with 8;21 chromosomal translocation and blast expression of the neural cell adhesion molecule. Cancer. 1994;73(8):2107-2112. (Pubitemid 24107965)
86. Au WY, Chan AC, Lie AK, et al. Recurrent isolated extramedullary relapses as granulocytic sarcomas following allogeneic bone marrow transplantation for acute myeloid leukemia. Bone Marrow Transplant. 1998;21(2):205-208. (Pubitemid 28044015)
87. Bakst R, Jakubowski A, Yahalom J. Recurrent neurotropic chloroma: report of a case and review of the literature. Adv Hematol. 2011;2011:854240.
88. Kottaridis PD, Ketley N, Peggs K, et al. An unusual case of intrapulmonary granulocytic sarcoma presenting as interstitial pneumonitis following allogeneic bone marrow transplantation for acute myeloid leukaemia and responding to donor lymphocyte infusion. Bone Marrow Transplant. 1999;24(7):807-809. (Pubitemid 29469284)
89. Wada A, Kobayashi N, Asanuma S, et al. Repeated donor lymphocyte infusions overcome a myeloid sarcoma of the stomach resulting from a relapse of acute myeloid leukemia after allogeneic cell transplantation in long-term survival of more than 10 years. Int J Hematol. 2011;93(1):118-122.
90. De Lima M, Giralt S, Thall PF, et al. Maintenance therapy with low-dose azacitidine after allogeneic hematopoietic stem cell transplantation for recurrent acute myelogenous leukemia or myelodys-plastic syndrome: a dose and schedule finding study. Cancer. 2010;116(23):5420-5431.
91. Chak LY, Sapozink MD, Cox RS. Extramedullary lesions in non-lymphocytic leukemia: results of radiation therapy. Int J Radiat Oncol Biol Phys. 1983;9(8):1173-1176. (Pubitemid 13041753)
92. Lo-Coco F, Avvisati G, Vignetti M, et al. Front-line treatment of acute promyelocytic leukemia with AIDA induction followed by risk-adapted consolidation for adults younger than 61 years: results of the AIDA-2000 trial of the GIMEMA Group. Blood. 2010;116(17):3171-3179.
93. Chang H, Shih LY, Kuo TT. Primary aleukemic myeloid leukemia cutis treated successfully with combination chemotherapy: report of a case and review of the literature. Ann Hematol. 2003;82(7):435-439. (Pubitemid 36949797)
94. Michel G, Boulad F, Small TN, et al. Risk of extramedullary relapse following allogeneic bone marrow transplantation for acute myelogenous leukemia with leukemia cutis. Bone Marrow Transplant. 1997;20(2):107-112. (Pubitemid 27356724)
95. Nisce LZ, Chu FC, Lee HS, et al. Total skin electron beam therapy for cutaneous lymphomas and leukemias. Int J Radiat Oncol Biol Phys. 1982;8(9):1587-1592. (Pubitemid 12001071)
96. Pepek JM, Paulino AC, Briones MA, Marcus RB Jr, Esiashvili N. Role of total skin electron beam therapy for leukemia cutis in pediatric patients. Pediatr Blood Cancer. 2008;50(5):1054-1055. (Pubitemid 351500187)
97. Rubin CM, Arthur DC, Meyers G, et al. Leukemia cutis treated with total skin irradiation. Cancer. 1985;55(11):2649-2652. (Pubitemid 15092153)
98. Imanaka K, Fujiwara K, Satoh K, et al. A case of aleukemic monocytic leukemia cutis treated with total body electron therapy. Radiat Med. 1988;6(5):229-231. (Pubitemid 19043527)
99. Bakst R, Yahalom J. Radiation therapy for leukemia cutis. Practical Radiat Oncol. 2011;1(3):182-187.
100. Solberg LA Jr, Wick MR, Bruckman JE. Doxorubicin-enhanced skin reaction after whole-body electron-beam irradiation for leukemia cutis. Mayo Clin Proc. 1980;55(11):711-715. (Pubitemid 11175364)
101. Chang H, Brandwein J, Yi QL, et al. Extramedullary infiltrates of AML are associated with CD56 expression, 11q23 abnormalities and inferior clinical outcome. Leuk Res. 2004;28(10):1007-1011. (Pubitemid 39037332)
102. Montesinos P, Rayon C, Vellenga E, et al. Clinical significance of CD56 expression in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based regimens. Blood. 2011;117(6):1799-1805.
103. Seymour JF, Pierce SA, Kantarjian HM, Keating MJ, Estey EH. Investigation of karyotypic, morphologic and clinical features in patients with acute myeloid leukemia blast cells expressing the neural cell adhesion molecule (CD56). Leukemia. 1994;8(5):823-826. (Pubitemid 24161088)
104. Garin-Chesa P, Fellinger EJ, Huvos AG, et al. Immunohistochemical analysis of neural cell adhesion molecules: differential expression in small round cell tumors of childhood and adolescence. Am J Pathol. 1991;139(2):275-286.
105. Evans AE, Gilbert ES, Zandstra R. The increasing incidence of central nervous system leukemia in children. (Children's Cancer Study Group A). Cancer. 1970;26(2):404-409.
106. Nesbit ME Jr, Robison LL, Ortega JA, et al. Testicular relapse in childhood acute lymphoblastic leukemia: association with pretreatment patient characteristics and treatment. A report for Children's Cancer Study Group. Cancer. 1980;45(8):2009-2016. (Pubitemid 10150413)
107. Cross AH, Goorha RM, Nuss R, et al. Acute myeloid leukemia with T-lymphoid features: a distinct biologic and clinical entity. Blood. 1988;72(2):579-587.
108. Kuwabara H, Nagai M, Yamaoka G, Ohnishi H, Kawakami K. Specific skin manifestations in CD56 positive acute myeloid leukemia. J Cutan Pathol. 1999;26(1):1-5. (Pubitemid 29041491)
109. Schwonzen M, Kuehn N, Vetten B, Diehl V, Pfreundschuh M. Phenotyping of acute myelomonocytic (AMMOL) and monocytic leukemia (AMOL): association of T-cell-related antigens and skin-infiltration in AMOL. Leuk Res. 1989;13(10):893-898. (Pubitemid 19284893)
110. Fuhlbrigge RC, Kieffer JD, Armerding D, Kupper TS. Cutaneous lymphocyte antigen is a specialized form of PSGL-1 expressed on skin-homing T cells. Nature. 1997;389(6654):978-981. (Pubitemid 27485690)
111. Petrella T, Meijer CJ, Dalac S, et al. TCL1 and CLA expression in agranular CD4/CD56 hematodermic neoplasms (blastic NK-cell lymphomas) and leukemia cutis. Am J Clin Pathol. 2004;122(2):307-313. (Pubitemid 38971364)
112. Giralt S, O'Brien S, Weeks E, Luna M, Kantarjian H. Leukemia cutis in acute promyelocytic leukemia: report of three cases after treatment with all-trans retinoic acid. Leuk Lymphoma. 1994;14(5):453-456. (Pubitemid 24282573)
113. Marchetti M, Falanga A, Giovanelli S, Oldani E, Barbui T. All-trans-retinoic acid increases adhesion to endothelium of the human promyelocytic leukaemia cell line NB4. Br J Haematol. 1996;93(2):360-366. (Pubitemid 26150026)